Trademark applications and grants for Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc has 144 trademark applications. The latest application filed is for "TALK ABOUT PAIN"
Patent Application | Date |
---|---|
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR 20220306606 - 17/505699 Alcacio; Timothy ;   et al. | 2022-09-29 |
MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES 20220259578 - 17/585365 Chakraborty; Tirtha ;   et al. | 2022-08-18 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS 20220257564 - 17/475606 Chu; Cathy ;   et al. | 2022-08-18 |
METHOD FOR TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS 20220249489 - 17/448147 HELLEDAY; Thomas ;   et al. | 2022-08-11 |
PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF 20220241206 - 17/475622 DOKOU; Eleni ;   et al. | 2022-08-04 |
NCAGE Code | 4LQG8 | VERTEX PHARMACEUTICALS INCORPORATED |
CAGE Code | 4LQG8 | VERTEX PHARMACEUTICALS INCORPORATED |
S.A.M. Registration | 4LQG8 [602478257] | VERTEX PHARMACEUTICALS INCORPORATED |
SEC | 0000864984 | VERTEX PHARMACEUTICALS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.